SCHEDULE 13G/A

AN2 Therapeutics, Inc.

Common Stock, $0.00001 par value per share · CUSIP: 037326105

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Adjuvant Global Health Technology Fund, L.P.

  Shares: 1,995,958 · Class: 6.7%

• Adjuvant Global Health Technology Fund DE, L.P.

  Shares: 377,542 · Class: 1.3%

• Adjuvant Capital GP, L.P.

  Shares: 2,373,500 · Class: 7.9%

• Adjuvant Capital Management, L.L.C.

  Shares: 2,373,500 · Class: 7.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.